Title:
Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis

dc.contributor.authorSaileyee Roychowdhury
dc.contributor.authorDeepika Joshi
dc.contributor.authorVinay Kumar Singh
dc.contributor.authorMohammed Faruq
dc.contributor.authorParimal Das
dc.date.accessioned2026-02-09T04:43:32Z
dc.date.issued2024
dc.description.abstractBackground: Amyotrophic lateral sclerosis (ALS) is an old onset devastating neurodegenerative disorder. Young-onset ALS cases especially sporadic ones who are between 25 and 45 years are rarely affected by the disease. Despite the identification of numerous candidate genes associated with ALS, the etiology of the disease remains elusive due to extreme genetic and phenotypic variability. The advent of affordable whole exome sequencing (WES) has opened new avenues for unraveling the disease’s pathophysiology better. Methods and results: We aimed to determine the genetic basis of an Indian-origin, young onset sporadic ALS patient with very rapid deterioration of the disease course without any cognitive decline who was screened for mutations in major ALS candidate genes by WES. Variants detected were reconfirmed by Sanger sequencing. The clinicopathological features were investigated and two heterozygous missense variants were identified: R452W, not previously associated with ALS, present in one of the four conserved C terminal domains in ANXA11 and R208W in SIGMAR1, respectively. Both of these variants were predicted to be damaging by pathogenicity prediction tools and various in silico methods. Conclusion: Our study revealed two potentially pathogenic variants in two ALS candidate genes. The genetic makeup of ALS patients from India has been the subject of a few prior studies, but none of them examined ANXA11 and SIGMAR1 genes so far. These results establish the framework for additional research into the pathogenic processes behind these variations that result in sporadic ALS disease and further our understanding of the genetic makeup of Indian ALS patients. © 2024 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases.
dc.identifier.doi10.1080/21678421.2024.2324896
dc.identifier.issn21678421
dc.identifier.urihttps://doi.org/10.1080/21678421.2024.2324896
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/49595
dc.publisherTaylor and Francis Ltd.
dc.subjectAmyotrophic lateral sclerosis
dc.subjectANXA11 mutation
dc.subjectgenetics
dc.subjectIndian ALS patient
dc.subjectmotor neuron disease
dc.subjectSIGMAR1 mutation
dc.subjectsporadic ALS
dc.titleGenetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis
dc.typePublication
dspace.entity.typeArticle

Files

Collections